Blog BIOTRONIK

2023 was a landmark year for BIOTRONIK – not simply in name or number – but in action. The company’s 60 th year of operations was a busy one for lifesaving innovations like the Amvia pacemaker and CRT-P family and Oscar catheter, to laying the groundwork for helping a whole new community of patients with the Prospera TM spinal cord stimulation system, a BIOTRONIK first.

Explore the Latest Research on AI in Medicine, Atrial Fibrillation Detection, Resorbable Scaffolds, Non-Contact Charge Density Mapping, and Spinal Cord Stimulation to Enhance Clinical Practice and Stay Ahead of the Curve

Pioneering spirit and passion for innovation – that's what BIOTRONIK stands for. This is also shown by the company’s flagship innovations: from the first German pacemaker to the GoldTip ablation catheter, a real innovation in electrophysiology that is still the gold standard today.

The Findings of the MATRIX Study Could Change Clinical Practice, Says Cardiac Rhythm Expert Dr. Ignasi Anguera Camos

Our colleagues from around the world show that it sometimes doesn't take much to make a difference

The first patient visit to BIOTRONIK in a long while met with excitement and enthusiasm

Women’s History Month is the perfect time to celebrate the incredible achievements of the women who have shaped the field of cardiology.

Biotronik’s Chief Procurement Officer Takes a Look at the New Statutory Regulations

With 2023 upon us, BIOTRONIK employees are no exception to the kind of motivated goal-setting we often see at this time of year. Whether it’s more sports, a more mindful approach to everyday life, or to quit smoking—it’s important to have as much support as possible. That’s why BIOTRONIK’s Health Program 2023 will work to empower employees to achieve their health-related goals. 2023’s edition places a special focus on improving mental health at work, alongside the company’s work to promote physical health.